JOIN OUR USA EAST COAST 2018 STRATEGY MEETING
13th November 2018 | The Westin Boston Waterfront
OUR UNIQUE FORMAT
The Bioinformatics Roundtable Discussions Strategy Meeting is free to attend for qualified end-users. These include Senior Executives of Biomedical Informatics, Scientific Computing and Digital Health (from medium to large Pharma, Biopharma and Biotech players) who aim to accelerate discovery, translational, clinical, CMC, and regulatory programs across the R&D pipeline, as well as thought leaders from Academia and regulatory authorities.
Thought leaders who will benefit from attending include CXOs, EVPs, SVPs, VPs, Executive Directors, Directors and Global Heads responsible for:
– R&D IT, Computational Biology/Sciences, Cloud Computing, Next-Gen Sequencing informatics, Clinical Research and Translational Informatics, Clinical Genomics, Data & Storage Management, Data Computing, Data Visualization & Exploration.
WHAT TO EXPECT
Interactive Roundtable Discussions
Attendees can proactively share and ask questions to their peers about the success of their work in an informal setting.
Director level one-to-one meetings
We provide opportunities to engage with one another in our strategy meeting in a series of pre-arranged business meetings by interacting face to face.
Tailor-fit and Personalized Agenda
Being able to experience different sessions is what makes our event unique that’s why our attendees can personalize and select sessions they want to participate in.
Several networking opportunities are in store for attendees to connect and build new relationships with their peers through luncheons, cocktails and informal introductions.
Thank you for reaching Proventa International
***The information you provided in this website is confidential and the company will strictly forbidden to share any part of these information with any third party without a written consent of the sender.
Our unique strategy meeting platform ensures that delegates can network with peers and benchmark their challenges whilst meeting a select number of supplier organizations that are currently at the forefront of innovation. This in turns helps them to save time and money associated in sourcing the best suppliers to procure solutions in an environment, which is 100% conducive to doing business.
If you are an exciting start-up trying to get your innovation in front global heads from the leading Pharmaceutical companies, or a mature market-leading conglomerate with legacy solutions trying to stay one step ahead of the competition – we are here to help!
WHAT PEOPLE SAY
Roundtable Discussion Format, Bioinformatics Strategy Meeting Europe 2015
Chief Information Officer
Its nice because they basically allowed people to engaged to discussions and questions. Academic and industry is very nice and informative
Ivan John Clement
Data Scientist - R&D
Its good because you really get the people to talk. They are willing to share their knowledge, the juniors are very eager to learn.
Manager Quality Assurance
The format is the beginning of breakthrough and integration, the level of delegates is very good and excellent, they learn a lot.
Founder & President
The kind of interaction is very interactive
Director & Professor
Because of diversity we really districts the points and all. People are very diversity and thoughtful in a round table.
Images coming soon
425 Summer St, Boston, MA 02210, USA
OUR MEDIA PARTNERS
Vice President Translational Medicine, Pierre Fabre
Alexandre Passioukov leads translational medicine efforts across oncology, CNS and dermatology therapeutic areas at Pierre-Fabre R&D involving a few CDx at the different al stage. Previously, Dr. Passioukov was leading translational medicine programs at Roche (Switzerland) with a special focus on precision medicine approaches for immune-oncology drugs. Prior to joining Roche, Alexandre served as Head of Translational Research at EORTC in Brussels, conducting structural translational medicine activities of European clinical research networks. Alexandre is MD with PhD in biology by Université Catholique de Louvain (UCL), where he was closely involved in the launch of 2 spin-off biotech companies: Coulter Pharma Belgium and Diatos.
Global Head of Operations & Informatics, Pharma Research & Early Development, Roche
Bryn gained his BSc and Ph.D. in pharmacology from the University of Bristol, UK. He joined Roche in Basel in 2006, and his role as Global Head of Informatics was expanded in 2014 to Global Head of Operations for Pharma Research and Early Development (pRED). He is also the Centre Head for pRED at the Roche Innovation Centre Basel.
Beyond Roche, Bryn is a visiting fellow at the University of Oxford where he is a member and former chairman of the scientific management committee for the Systems Approaches to Biomedical Sciences Centre for Doctoral Training. He has been recognised by Fierce Biotech IT in their list of Top 10 Biotech Techies and by the Big Data Leaders Forum in their Top 50 Big Data Influencers in Precision Medicine.
Global Head of Integrated Data Sciences, Novartis
Doctor Marc obtained a Ph.D. in Computational Science from Paris University before completing a systems biology-oriented postdoctoral fellowship in the lab of George Church at Harvard Medical School. He then worked for Aventis and Sanofi before joining Novartis a decade 10 years ago. At Novartis, his team developed tools to improve and expedite Translational Medicine data analysis and decision-making. He is also leading the data standardization and visualization work of the Innovative Medicine Initiative eTOX project.
Global Head of Knowledge Management PTD, Roche
Etzard leads the global Information / Knowledge Management effort in Pharma Technical Development for F. Hoffmann-La Roche in Basel, with a focus on processes and tools for effective knowledge utilisation. Etzard has worked at the interface of the Life- and Computer-Sciences for more than 20 years, in technical, managerial as well as strategic roles. Before joining Roche, Etzard worked as CIO at the Jackson Lab (a US based genomics research institutes with 1800 employees), and was CTO for the Life Sciences at Hewlett Packard. Etzard has earned academic degrees in both Biology, Bio-Informatics and Informatics, with a PhD in Computer Science from ETH Zurich on "A Scalable Architecture for Scientific Database